Low-level light therapy administered before and after cataract surgery is a safe and effective approach for preventing dry eye disease in patients undergoing the procedure, a clinical trial shows. Medscape Medical News
Tag: Ophthalmology
Does Blockage in Retinal Artery Signal Heart Issues?
Retinal artery occlusion is more than just an ocular event — it also serves as an independent marker of an increased risk for subsequent cardiovascular events, a new meta-analysis shows. Medscape Medical News
US FDA Declines to Approve Outlook Therapeutics’ Eye Disease Drug, Shares Plummet
Outlook Therapeutics said on Thursday the U.S. health regulator has again declined to approve its experimental eye drug, citing a lack of substantial evidence of… Reuters Health Information
Advances in Neovascular Macular Degeneration From ASRS 2025
Advances in neovascular macular degeneration, presented at ASRS 2025, include efficacy of aflibercept 8 mg as well as emerging gene therapies, as reported by Dr Sunir Garg. Medscape
AI-Powered Model Can Classify Types of Optic Nerve Damage
A deep-learning analysis of three-dimensional optical coherence tomography scans shows promising accuracy in distinguishing among glaucoma, optic neuropathy, optic neuritis, and healthy eyes, according to a recent study. Medscape Medical News
Diabetic Macular Edema: Second-Gen Anti-VEGFs Lead the Way
Medscape Medical News
Vitamin D Deficiency Tied to Cataract Risk in Young Adults
Low serum levels of vitamin D are associated with an increased risk for development of cataracts, particularly among young people, new research shows. Medscape Medical News
AMD Light Therapy Restores Vision Gains Post-Treatment Pause
A tabletop light therapy device led to vision improvements over 4.5 years and a long pause between treatments in people with dry age-related macular degeneration. Medscape Medical News
Long-Term Use of Metformin May Prevent AMD in Diabetes
Patients with diabetes who use metformin for at least 5 consecutive years are less likely to develop AMD, particularly the dry type, a recent study shows. Medscape Medical News
New Anti-VEGF Agents Extend Dosing Intervals in Wet AMD
New anti-VEGF agents for wet age-related macular degeneration can extend injection intervals to 3-5 months but may increase inflammation risk, prompting calls for tailored treatment plans. Medscape Medical News
Rare Eye Disease Gets First NHS Drug Recommendation
NICE’s recommendation of idebenone (Raxone) for Leber hereditary optic neuropathy offers hope for patients against visual impairment. Medscape News UK
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
Study Counters Others on GLP-1, Diabetic Retinopathy Link
An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy complications. Medscape Medical News
As Copay Aid Recedes, Retina Treatment ‘Unsustainable’
A new study finds cuts in copay assistance for retina injections are harming lower-income communities and leading to poorer vision outcomes. Medscape Medical News
Port Delivery System Outperforms Injections for DME
In patients with diabetic macular edema in both eyes, the port delivery system in one eye achieves a superior anatomical response than intravitreal injection the other, a new study shows. Medscape Medical News
Retina Tear Raises Detachment Risk After Cataract Surgery
Delaying cataract surgery 6 months or more after laser for retina tears reduces the risk for retinal detachment by half, a new study shows. Medscape Medical News
FDA Approves of VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
FDA Approves VIZZ Eye Drops to Treat Presbyopia
The effects of once-daily acelidine-based treatment last for up to 10 hours. Medscape Medical News
GLP-1 RAs May Up Optic Neuropathy Risk in Seniors With Diabetes
Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes, a study of Medicare enrollees shows. Medscape Medical News
GLP-1 Users May Face Optic Nerve Damage Risk in First Year
A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, especially with liraglutide and among people without diabetes or obesity. Medscape Medical News